Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
Metabolism: Clinical and Experimental
|
March 7, 2001
Postprandial lipemia and associated metabolic disturbances in healthy and hyperlipemic postmenopausal women
M Pirro, G Lupattelli, D Siepi, et al.
Journal of Clinical Pharmacy and Therapeutics
|
July 20, 2007
Endothelial dysfunction in vivo is related to monocyte resistin mRNA expression
G Lupattelli, S Marchesi, T Ronti, et al.
Annals of the Rheumatic Diseases
|
December 16, 2003
Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity
G Vaudo, S Marchesi, R Gerli, et al.
VASA. Zeitschrift Fur Gefasskrankheiten
|
November 17, 2006
Natriuretic peptides levels are related to HDL-cholesterol with no influence on endothelium dependent vasodilatation
G Lupattelli, S Marchesi, D Siepi, et al.
Journal of Clinical Pharmacy and Therapeutics
|
November 25, 2003
Effects of fenofibrate on endothelial function and cell adhesion molecules during post-prandial lipemia in hypertriglyceridemia
S Marchesi, G Lupattelli, R Lombardini, et al.
Annals of Nutrition & Metabolism
|
March 27, 2002
Postprandial endothelial impairment and reduced glutathione levels in postmenopausal women
D Siepi, S Marchesi, G Lupattelli, et al.
Reumatismo
|
March 19, 2005
[Subclinical atherosclerosis in young patients with rheumatoid arthritis and low disease activity]
E Bartoloni Bocci, S Marchesi, F Delle Monache, et al.
ESMO Gastrointestinal Oncology
|
April 17, 2026
Early- and advanced-stage MSI-H non-colorectal cancers: best management and challenges in 2025
R Fazio, M Ambrosini, A Raimondi, et al.
Annals of Human Genetics
|
May 17, 2002
An immunogenetic map of Lombardy (Northern Italy)
M Martinetti, A Degioanni, A M D'Aronzo, et al.
ESMO Open
|
November 8, 2025
Second-line 5-FU plus nanoliposomal irinotecan versus FOLFOX/XELOX in metastatic pancreatic cancer after gemcitabine-nab-paclitaxel failure: a propensity score-matched analysis
G Trovato, D Rossini, A Guidolin, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
Metabolism: Clinical and Experimental
|
March 7, 2001
Postprandial lipemia and associated metabolic disturbances in healthy and hyperlipemic postmenopausal women
M Pirro, G Lupattelli, D Siepi, et al.
Journal of Clinical Pharmacy and Therapeutics
|
July 20, 2007
Endothelial dysfunction in vivo is related to monocyte resistin mRNA expression
G Lupattelli, S Marchesi, T Ronti, et al.
Annals of the Rheumatic Diseases
|
December 16, 2003
Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity
G Vaudo, S Marchesi, R Gerli, et al.
VASA. Zeitschrift Fur Gefasskrankheiten
|
November 17, 2006
Natriuretic peptides levels are related to HDL-cholesterol with no influence on endothelium dependent vasodilatation
G Lupattelli, S Marchesi, D Siepi, et al.
Journal of Clinical Pharmacy and Therapeutics
|
November 25, 2003
Effects of fenofibrate on endothelial function and cell adhesion molecules during post-prandial lipemia in hypertriglyceridemia
S Marchesi, G Lupattelli, R Lombardini, et al.
Annals of Nutrition & Metabolism
|
March 27, 2002
Postprandial endothelial impairment and reduced glutathione levels in postmenopausal women
D Siepi, S Marchesi, G Lupattelli, et al.
Reumatismo
|
March 19, 2005
[Subclinical atherosclerosis in young patients with rheumatoid arthritis and low disease activity]
E Bartoloni Bocci, S Marchesi, F Delle Monache, et al.
ESMO Gastrointestinal Oncology
|
April 17, 2026
Early- and advanced-stage MSI-H non-colorectal cancers: best management and challenges in 2025
R Fazio, M Ambrosini, A Raimondi, et al.
Annals of Human Genetics
|
May 17, 2002
An immunogenetic map of Lombardy (Northern Italy)
M Martinetti, A Degioanni, A M D'Aronzo, et al.
ESMO Open
|
November 8, 2025
Second-line 5-FU plus nanoliposomal irinotecan versus FOLFOX/XELOX in metastatic pancreatic cancer after gemcitabine-nab-paclitaxel failure: a propensity score-matched analysis
G Trovato, D Rossini, A Guidolin, et al.
Page
of 3